BRAF and Hyperkeratosis: The described patient had a BRAF mutation-positive metastatic papillary thyroid carcinoma and was treated with a BRAF inhibitor on a clinical trial and developed Dupuytren’s contractures of both hands, palmar hyperkeratosis, a keratosis pilaris-like eruption and erythema nodosum [5].